Pharmaceutical Greed and Its Consequences.
作者信息
Jacobs Henry E
出版信息
Conn Med. 2016 May;80(5):315-6.
PMID:27328583
Abstract
摘要
相似文献
1
Pharmaceutical Greed and Its Consequences.制药行业的贪婪及其后果。
Conn Med. 2016 May;80(5):315-6.
2
A perspective on US drug reimportation.对美国药品再进口的一种观点。
JAMA. 2005 Jan 19;293(3):358-62. doi: 10.1001/jama.293.3.358.
3
Gift giving.赠送礼物。
S D J Med. 2002 Dec;55(12):513-4.
4
FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.美国食品药品监督管理局认可将第一世界国家的药品监管机构作为缓解美国药品短缺的一种方式。
Am J Health Syst Pharm. 2012 Oct 1;69(19):1626, 1628. doi: 10.2146/ajhp120478.
5
Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry.
Int J Health Serv. 1974 Winter;4(1):147-55. doi: 10.2190/DCU8-7F68-E48J-4ER5.
6
Your health in the 21st century. A better safety net.21世纪的健康。更完善的安全保障。
Newsweek. 2005 Summer;145(26A):70-2.
7
The case for less, not more, US FDA regulation.美国食品药品监督管理局应减少而非增加监管力度。
Pharmacoeconomics. 2011 Aug;29(8):637-40. doi: 10.2165/11585740-000000000-00000.
8
ASHP, other groups, advise FDA about solving counterfeit drug problems.
Am J Health Syst Pharm. 2003 Dec 1;60(23):2406, 2408, 2411. doi: 10.1093/ajhp/60.23.2406.
9
Can the Food and Drug Administration ensure that our pharmaceuticals are safely manufactured?美国食品药品监督管理局能确保我们的药品是安全生产的吗？
Arch Intern Med. 2009 Oct 12;169(18):1655-6. doi: 10.1001/archinternmed.2009.304.
10
Drug development, regulation, and the practice of medicine.药物研发、监管与医学实践。
JAMA. 1974 Sep 9;229(11):1457-61.
Zotero 插件